Ameriprise’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,327,110
Closed -$3.65M 4131
2024
Q3
$3.65M Buy
2,327,110
+234,400
+11% +$417K ﹤0.01% 2582
2024
Q2
$3.52M Buy
2,092,710
+674,760
+48% +$1.21M ﹤0.01% 2557
2024
Q1
$3.4M Sell
1,417,950
-472,250
-25% -$1.01M ﹤0.01% 2601
2023
Q4
$2.89M Buy
1,890,200
+675,522
+56% +$803K ﹤0.01% 2688
2023
Q3
$1.32M Buy
1,214,678
+376,270
+45% +$660K ﹤0.01% 3018
2023
Q2
$1.92M Buy
+838,408
New +$2.23M ﹤0.01% 2894
2018
Q4
Sell
-164,581
Closed -$1.76M 3720
2018
Q3
$1.76M Buy
+164,581
New +$1.89M ﹤0.01% 2858
2017
Q3
Sell
-76,633
Closed -$1.26M 3721
2017
Q2
$1.26M Buy
+76,633
New +$1.19M ﹤0.01% 2827
2015
Q2
Sell
-1,611
Closed -$11K 4051
2015
Q1
$11K Buy
+1,611
New +$11K ﹤0.01% 3791
2014
Q4
Sell
-749
Closed -$7K 4106
2014
Q3
$7K Sell
749
-103
-12% -$1.1K ﹤0.01% 5003
2014
Q2
$10K Buy
852
+48
+6% +$516 ﹤0.01% 4659
2014
Q1
$10K Buy
804
+92
+13% +$1.18K ﹤0.01% 4526
2013
Q4
$9K Sell
712
-2,287
-76% -$36.4K ﹤0.01% 4423
2013
Q3
$50K Buy
2,999
+105
+4% +$1.76K ﹤0.01% 3814
2013
Q2
$44K Buy
+2,894
New +$44K ﹤0.01% 3789

Other funds holding LXRX